LionBio Therapeuticshttps://lion.bio/

Your landing page’s weakest score is Trust.

Fix Trust
75Growth scoreupdated

category scores

category scoresShowHide

Trust

64Fair

Proof that the product is real, competent, and safe to try.

LionBio Therapeutics
Rani Therapeutics
Trust read
LionBio Therapeutics"Columbia — University spinout technology" credential in the stats strip
Rani Therapeutics"3 Phase 1 studies completed" stat badge
Entera BioNo visible trust signal identified.
Oramed PharmaceuticalsNo visible trust signal identified.
Structure TherapeuticsNo visible trust signal identified.

Information hierarchy

73Fair

Does the design help or inhibit what the page is trying to say?

Information hierarchy annotations on the desktop capture123
  1. Explore our research — Dark green on black hero gives the primary CTA the lowest contrast of any button on the page.
  2. View open roles — White secondary button outshines the primary CTA at equal size, splitting the click between two actions.
  3. Careers nav pill — Reuses the primary CTA's green fill, pulling first-glance attention to the top-right exit.

CTA

76Fair

Copy, size, verb, cost-feel — does the primary CTA earn the click?

LionBio Therapeutics

How LionBio Therapeutics compares

Recommended rewrites

Mobile web

78Fair

The phone experience as a first-class citizen.

LionBio Therapeutics mobile capture for Mobile web

What works

What to improve

Value props

82Strong

Title, subtitle, hero — do they sell the product's true value?

LionBio Therapeutics’s headlineThe world's first GLP-1s taken through your nose.Direct-to-brain and less nausea. Next gen intranasal peptide therapeutics powered by our precision nanoparticle technology.

Working

Could improve